
    
      The primary objective of the study is to evaluate the hemostatic efficacy and safety in the
      recipients of platelets obtained from buffy coat of multiple donors (five), cryopreserved
      with DMSO using a new patented method, up to 9 months from the collection.

      Further goals are the registration of any related- adverse event (idiosyncrasy, allergy,
      toxicity)
    
  